… Bladder cancer (BC) is the sixth most prevalent cancer in both genders and the fourth in
males worldwide (incidence of 9.6 and 2.4 per 100,000 in men and women, respectively; age-…

… Bladder cancer is the 8th most common cancer with 74,000 new cases in the United States
… Non-muscle invasive bladder cancer (NMIBC) accounts for 75% of all bladder cancer cases. …

… This review focuses on risk assessment and prediction tools for bladder cancer (BCa). …
We looked at models that aim to predict outcomes for patients with bladder cancer (BCa). We …

… We report a comprehensive analysis of 412 muscle-invasive bladder cancers characterized
by multiple TCGA analytical platforms. Fifty-eight genes were significantly mutated, and the …

… a comprehensive multi-regional analysis and an in-depth characterization of the heterogeneity
in advanced bladder cancer … Our analysis showed a clonal origin for all tumour regions in …

… [16]In separate analyses of the data from Baker et al.,[17]our colleagues[18]estimated even
higher lifetime costs of bladder cancer. In this analysis, the lifetime cost of bladder cancer …

… However, similar studies are rare in bladder cancer. Furthermore, comprehensive analysis
of muscle-invasive bladder cancer-associated lncRNAs and miRNAs in a whole genome wide…

… in bladder cancer (BCa) has not been deeply investigated thus far. Gene expression data
are available for BCa, and bioinformatics analysis … Our analysis identified the Notch receptors …

… of bladder cancer, we analyzed urine from 115 patients with cancer and 59 control urine …
The methylation difference between urine from healthy individuals and patients was highly …

… analysis was conducted using bioinformatics approach to assess the potential relationship
between bladder cancer … compounds were obtained from The Cancer Genome Atlas (TCGA) …